Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 0 | 0 | 0 | 653 |
| Cost of Goods | N/A | N/A | N/A | N/A | 5,401 |
| Gross Profit | N/A | N/A | N/A | N/A | -4,748 |
| Operating Expenses | 19,298 | 45,399 | 26,874 | 84,326 | 76,665 |
| Operating Income | 19,298 | -45,399 | -26,874 | -84,326 | -81,012 |
| Interest Expense | 0 | 0 | 134 | 288 | 0 |
| Other Income | -38,506 | 831 | -169 | 28 | -1,047 |
| Pre-tax Income | -19,208 | -44,568 | -27,177 | -84,586 | -82,059 |
| Income Tax | N/A | N/A | N/A | N/A | 201 |
| Net Income Continuous | -19,208 | -44,568 | -27,177 | -84,586 | -82,260 |
| Minority Interests | N/A | N/A | 15 | -8 | N/A |
| Net Income | $-19,208 | $-44,568 | $-27,192 | $-84,578 | $-82,260 |
| EPS Basic Total Ops | -533.55 | -633.62 | -3,427.42 | -62,740.41 | -7,482.76 |
| EPS Basic Continuous Ops | -533.72 | -633.91 | -3,424.99 | -62,703.32 | -7,479.23 |
| EPS Diluted Total Ops | -533.55 | -633.62 | -3,427.42 | -62,740.41 | -7,482.76 |
| EPS Diluted Continuous Ops | -533.72 | -633.91 | -3,424.99 | -62,703.32 | -7,479.23 |
| EBITDA(a) | $-18,959 | $-44,347 | $-26,842 | $-84,298 | $-78,115 |